HuGE Literature Finder
Records
1
-
4
Do genetic variations in proximal tubule transporters influence tenofovir-induced renal dysfunction? An exploratory study in a Ghanaian population. The Journal of antimicrobial chemotherapy 2020 Feb . Neary M, Olagunju A, Sarfo F, Phillips R, Moss D, Owen A, Chadwick |
A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial. Journal of clinical pharmacology 2018 May . Lui Gabrielle, Treluyer Jean-Marc, Fresneau Brice, Piperno-Neumann Sophie, Gaspar Nathalie, Corradini Nadège, Gentet Jean-Claude, Marec Berard Perrine, Laurence Valérie, Schneider Pascale, Entz-Werle Natacha, Pacquement Hélène, Millot Frédéric, Taque Sophie, Freycon Claire, Lervat Cyril, Le Deley Marie Cécile, Mahier Ait Oukhatar Céline, Brugieres Laurence, Le Teuff Gwénaël, Bouazza Naïm, |
Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients. Antimicrobial agents and chemotherapy 2015 Jun 59 (6): 3240-5. Rungtivasuwan Kanokrat, Avihingsanon Anchalee, Thammajaruk Narukjaporn, Mitruk Siwaporn, Burger David M, Ruxrungtham Kiat, Punyawudho Baralee, Pengsuparp Thiti |
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009 Jun 48 (11): e108-16. Rodríguez-Nóvoa Sonia, Labarga Pablo, Soriano Vincent, Egan Deirdre, Albalater Marta, Morello Judit, Cuenca Lorena, González-Pardo Gema, Khoo Saye, Back David, Owen Andr |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: